scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1037626383 |
P356 | DOI | 10.1186/CC7733 |
P932 | PMC publication ID | 2688146 |
P698 | PubMed publication ID | 19250547 |
P5875 | ResearchGate publication ID | 24145142 |
P50 | author | Alexander Melamed | Q47703865 |
P2093 | author name string | Frank J Sorvillo | |
P2860 | cites work | Deaths from cysticercosis, United States | Q24652722 |
Hospitalized cancer patients with severe sepsis: analysis of incidence, mortality, and associated costs of care | Q24799756 | ||
Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care | Q27860820 | ||
The epidemiology of sepsis in the United States from 1979 through 2000 | Q29547760 | ||
The pathophysiology and treatment of sepsis | Q29619103 | ||
The immunopathogenesis of sepsis | Q29622909 | ||
Using multiple cause-of-death data to investigate associations and causality between conditions listed on the death certificate | Q31108896 | ||
Deaths: final data for 2005. | Q31157028 | ||
The effect of age on the development and outcome of adult sepsis | Q34479183 | ||
Racial variation in the incidence, care, and outcomes of severe sepsis: analysis of population, patient, and hospital characteristics | Q37287126 | ||
The role of infection and comorbidity: Factors that influence disparities in sepsis | Q37588175 | ||
Alcohol dependence is independently associated with sepsis, septic shock, and hospital mortality among adult intensive care unit patients. | Q39780554 | ||
The systemic inflammatory response syndrome | Q40327630 | ||
Gender differences in cytokine secretion by human peripheral blood mononuclear cells: role of estrogen in modulating LPS-induced cytokine secretion in an ex vivo septic model. | Q43792641 | ||
Increase in National Hospital Discharge Survey rates for septicemia--United States, 1979-1987. | Q44017272 | ||
Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group | Q45787461 | ||
Decreasing listeriosis mortality in the United States, 1990-2005. | Q45969835 | ||
Changing trends in hepatitis C-related mortality in the United States, 1995-2004. | Q46370317 | ||
Cirrhosis as a risk factor for sepsis and death: analysis of the National Hospital Discharge Survey | Q47630913 | ||
A multiple cause-of-death analysis of asthma mortality in the United States, 1990-2001. | Q47682702 | ||
Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. | Q53238938 | ||
Pressure ulcers: more lethal than we thought? | Q53272201 | ||
American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis | Q68141412 | ||
Accuracy of death certificate completion: the need for formalized physician training | Q70994408 | ||
Gene variants of the bactericidal/permeability increasing protein and lipopolysaccharide binding protein in sepsis patients: gender-specific genetic predisposition to sepsis | Q73928186 | ||
Protection of human subjects | Q77094396 | ||
Occurrence and outcomes of sepsis: influence of race | Q79667927 | ||
Sepsis | Q80150077 | ||
Facing the challenge: decreasing case fatality rates in severe sepsis despite increasing hospitalizations | Q81455611 | ||
Hepatitis A--related mortality in California, 1989-2000: analysis of multiple cause-coded death data | Q81691005 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | United States of America | Q30 |
sepsis | Q183134 | ||
P304 | page(s) | R28 | |
P577 | publication date | 2009-02-27 | |
P1433 | published in | Critical Care | Q5186602 |
P1476 | title | The burden of sepsis-associated mortality in the United States from 1999 to 2005: an analysis of multiple-cause-of-death data | |
P478 | volume | 13 |
Q37210164 | 'Relation, association, attribution ...' - the multiple faces of death in critical care medicine |
Q89144654 | A national Infection in Critical Care Quality Improvement Programme for England: A survey of stakeholder priorities and preferences |
Q33750549 | A new role for statins in sepsis |
Q36367878 | A widened pulse pressure: a potential valuable prognostic indicator of mortality in patients with sepsis |
Q55542525 | Acquired immunological imbalance after surgery with cardiopulmonary bypass due to epigenetic over-activation of PU.1/M-CSF. |
Q30000073 | An Agent-Based Model of a Hepatic Inflammatory Response to Salmonella: A Computational Study under a Large Set of Experimental Data |
Q34570965 | Antihypertensive agents acting on the renin-angiotensin system and the risk of sepsis |
Q36633622 | Association of gender with outcomes in critically ill patients |
Q35658084 | Atrial natriuretic peptide protects against Staphylococcus aureus-induced lung injury and endothelial barrier dysfunction |
Q33901374 | Bacterial bloodstream infections in a tertiary infectious diseases hospital in Northern Vietnam: aetiology, drug resistance, and treatment outcome. |
Q27003122 | Bench-to-bedside review: Rapid molecular diagnostics for bloodstream infection--a new frontier? |
Q41419294 | Blood Lactate Levels Cutoff and Mortality Prediction in Sepsis-Time for a Reappraisal? a Retrospective Cohort Study. |
Q33822820 | Cell-type-specific crosstalk between p38 MAPK and Rho signaling in lung micro- and macrovascular barrier dysfunction induced by Staphylococcus aureus-derived pathogens |
Q38841451 | Changes in B-type Natriuretic Peptide and Related Hemodynamic Parameters Following a Fluid Challenge in Critically Ill Patients with Severe Sepsis or Septic Shock |
Q47157015 | Characterising Pre-pubertal Resistance to Death from Endotoxemia |
Q40052545 | Childhood tolerance of severe influenza: a mortality analysis in mice |
Q33889500 | Congenital cytomegalovirus mortality in the United States, 1990-2006. |
Q43484738 | Dependence of All-Cause Standardized In-Hospital Mortality on Sepsis Mortality Between 2005 and 2010. |
Q42163931 | Development of PCR-based method for detection of Enterobacteriaceae in septicemia |
Q42849488 | Effects of Microbubbles and Ultrasound on the Microcirculation: Observation on the Hamster Cheek Pouch |
Q28072231 | Epidemiologic trends of sepsis in western countries |
Q36381890 | Epidemiological and clinical characteristics of community-acquired severe sepsis and septic shock: a prospective observational study in 12 university hospitals in Korea. |
Q47134537 | Epidemiology and impact on all-cause mortality of sepsis in Norwegian hospitals: A national retrospective study. |
Q39125676 | Epitope specificity of anti-Adrenomedullin antibodies determines efficacy of mortality reduction in a cecal ligation and puncture mouse model |
Q47740257 | G Protein-Coupled Receptor Kinases in the Inflammatory Response and Signaling. |
Q26801467 | G-protein-coupled receptor kinases in inflammation and disease |
Q33779736 | Gender dimorphism of the cardiac dysfunction in murine sepsis: signalling mechanisms and age-dependency |
Q36076723 | Growing burden of sepsis-related mortality in northeastern Italy: a multiple causes of death analysis |
Q34681390 | HIV and hepatitis C mortality in Massachusetts, 2002-2011: spatial cluster and trend analysis of HIV and HCV using multiple cause of death |
Q26861647 | Healthcare disparities in critical illness |
Q37585971 | Heterogeneity among septic shock patients in a set of immunoregulatory markers. |
Q36111898 | High Israeli mortality rates from diabetes and renal failure - Can international comparison of multiple causes of death reflect differences in choice of underlying cause? |
Q33739254 | High mortality due to sepsis in Native Hawaiians and African Americans: The Multiethnic Cohort |
Q36747916 | Hospital Incidence and Mortality Rates of Sepsis |
Q35695065 | Host cell invasion by Staphylococcus aureus stimulates the shedding of microvesicles |
Q34894900 | How do we use therapeutic drug monitoring to improve outcomes from severe infections in critically ill patients? |
Q38849571 | ICU Admission Source as a Predictor of Mortality for Patients With Sepsis |
Q97543759 | Infer Cause of Death for Population Health Using Convolutional Neural Network |
Q42223252 | Inhibitor of nuclear factor-κB, SN50, attenuates lipopolysaccharide-induced lung injury in an isolated and perfused rat lung model |
Q26823225 | Lysosome and Cytoskeleton Pathways Are Robustly Enriched in the Blood of Septic Patients: A Meta-Analysis of Transcriptomic Data |
Q55714676 | Manipulation of nitric oxide levels with a modified hydroxyethyl starch molecule. |
Q94561554 | Mesenchymal Stem Cell-Derived Extracellular Vesicles: A Novel Cell-Free Therapy for Sepsis |
Q38217239 | Metabolic theory of septic shock. |
Q38765627 | MiRNA-Mediated Macrophage Polarization and its Potential Role in the Regulation of Inflammatory Response |
Q39610557 | Mortality Trends of Acute Respiratory Distress Syndrome in the United States from 1999 to 2013. |
Q28551029 | Murine Lung Cancer Increases CD4+ T Cell Apoptosis and Decreases Gut Proliferative Capacity in Sepsis |
Q89062820 | Murine Pancreatic Cancer Alters T Cell Activation and Apoptosis and Worsens Survival After Cecal Ligation and Puncture |
Q39215428 | Myeloid nuclear differentiation antigen, neutrophil apoptosis and sepsis |
Q33702376 | National variation in United States sepsis mortality: a descriptive study |
Q38995613 | No relationship between red blood cell distribution width and microcirculatory alterations in septic patients. |
Q35178692 | Oxidized phospholipids protect against lung injury and endothelial barrier dysfunction caused by heat-inactivated Staphylococcus aureus |
Q59808511 | Park 7: A Novel Therapeutic Target for Macrophages in Sepsis-Induced Immunosuppression |
Q40420550 | Passive therapy with humanized anti-staphylococcal enterotoxin B antibodies attenuates systemic inflammatory response and protects from lethal pneumonia caused by staphylococcal enterotoxin B-producing Staphylococcus aureus |
Q42665462 | Patient safety first... a California partnership for health |
Q48235160 | Pre-existing malignancy results in increased prevalence of distinct populations of CD4+ T cells during sepsis. |
Q36610107 | Predictors of early progression to severe sepsis or shock among emergency department patients with nonsevere sepsis |
Q26864623 | Pregnancy-Associated Severe Sepsis: Contemporary State and Future Challenges |
Q64129978 | Prevalence, Underlying Causes, and Preventability of Sepsis-Associated Mortality in US Acute Care Hospitals |
Q39070066 | Pro-inflammatory cytokines mediate GPCR dysfunction |
Q36305283 | Procalcitonin, MR-Proadrenomedullin, and Cytokines Measurement in Sepsis Diagnosis: Advantages from Test Combination |
Q36333229 | Public Awareness of Sepsis Is Low in Sweden |
Q42182713 | Real-time imaging reveals endothelium-mediated leukocyte retention in LPS-treated lung microvessels |
Q35800104 | Reported co-infection deaths are more common in early adulthood and among similar infections. |
Q60054361 | Risk Factors for Septicemia Deaths and Disparities in a Longitudinal US Cohort |
Q35230688 | Role of cytokines as a double-edged sword in sepsis |
Q36044317 | Role of interleukin-6 in hemopoietic and non-hemopoietic synergy mediating TLR4-triggered late murine ileus and endotoxic shock |
Q35550946 | Sepsis Pathogen Identification |
Q30659204 | Sepsis-associated mortality in England: an analysis of multiple cause of death data from 2001 to 2010. |
Q34558763 | Sepsis-related deaths in Brazil: an analysis of the national mortality registry from 2002 to 2010 |
Q64137586 | Sepsis-related mortality in China: a descriptive analysis |
Q38735177 | Structural basis for endotoxin neutralization by the eosinophil cationic protein. |
Q39327160 | Surviving sepsis? |
Q36945107 | The Changing Epidemiology and Definitions of Sepsis |
Q40736618 | The Early Chain of Care in Patients with Bacteraemia with the Emphasis on the Prehospital Setting. |
Q33591270 | The era of molecular and other non-culture-based methods in diagnosis of sepsis |
Q38630138 | The nuances of NO synthase regulation in sepsis: Could targeting BH4 be the answer? |
Q55032528 | The relative resistance of children to sepsis mortality: from pathways to drug candidates. |
Q34427050 | Therapeutic interventions in sepsis: current and anticipated pharmacological agents |
Q35091046 | Timing of norepinephrine in septic patients: NOT too little too late |
Q86061493 | Trends in hospitalizations of patients with sepsis and factors associated with inpatient mortality in the Region of Madrid, 2003–2011 |
Q35606877 | Update in hospital medicine for the general internist 2010-2011. |
Search more.